Denhaerynck K - Search Results

1

Predicting blood pressure outcomes using single-item physician-administered measures: a retrospective pooled analysis of observational studies in Belgium.

Villa L, Sun D, Denhaerynck K, Vancayzeele S, Brié H, Hermans C, Aerts A, Levengood M, MacDonald K, Abraham I. Villa L, et al. Among authors: denhaerynck k. Br J Gen Pract. 2015 Jan;65(630):e9-15. doi: 10.3399/bjgp15X683101. Br J Gen Pract. 2015. PMID: 25548319 Free PMC article.

2

Validity testing of the Long-Term Medication Behavior Self-Efficacy Scale.

Denhaerynck K, Abraham I, Gourley G, Drent G, De Vleeschouwer P, Papajcik D, Lince E, De Geest S. Denhaerynck K, et al. J Nurs Meas. 2003 Winter;11(3):267-82. doi: 10.1891/jnum.11.3.267.61271. J Nurs Meas. 2003. PMID: 15633781

3

Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).

Van der Niepen P, Woestenburg A, Brié H, Vancayzeele S, MacDonald K, Denhaerynck K, Lee C, Hermans C, Abraham I. Van der Niepen P, et al. Among authors: denhaerynck k. Ann Pharmacother. 2009 May;43(5):849-61. doi: 10.1345/aph.1L576. Epub 2009 Apr 7. Ann Pharmacother. 2009. PMID: 19351876 Clinical Trial.

4

Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study).

Swimberghe S, Ghislain PD, Daci E, Allewaert K, Denhaerynck K, Hermans C, Pacheco C, Vancayzeele S, Macdonald K, Abraham I. Swimberghe S, et al. Among authors: denhaerynck k. Ann Dermatol. 2013 Feb;25(1):28-35. doi: 10.5021/ad.2013.25.1.28. Epub 2013 Feb 14. Ann Dermatol. 2013. PMID: 23467644 Free PMC article.

5

Hierarchical modeling of patient and physician determinants of blood pressure outcomes in adherent vs nonadherent hypertensive patients: pooled analysis of 6 studies with 14,646 evaluable patients.

Abraham I, Van Camp Y, Villa L, Denhaerynck K, Sun D, Vancayzeele S, Brié H, Aerts A, Hermans C, MacDonald K. Abraham I, et al. Among authors: denhaerynck k. J Clin Hypertens (Greenwich). 2013 Sep;15(9):663-73. doi: 10.1111/jch.12163. Epub 2013 Jul 12. J Clin Hypertens (Greenwich). 2013. PMID: 24034660 Free PMC article.

6

Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS study.

Rakic JM, Leys A, Brié H, Denhaerynck K, Pacheco C, Vancayzeele S, Hermans C, Macdonald K, Abraham I. Rakic JM, et al. Among authors: denhaerynck k. Clin Ophthalmol. 2013;7:1849-58. doi: 10.2147/OPTH.S49385. Epub 2013 Sep 19. Clin Ophthalmol. 2013. PMID: 24092964 Free PMC article.

7

Remission over 3 years in patients with Paget disease of bone treated with a single intravenous infusion of 5 mg zoledronic acid.

Devogelaer JP, Geusens P, Daci E, Gielen E, Denhaerynck K, Macdonald K, Hermans C, Vancayzeele S, Abraham I, Boonen S. Devogelaer JP, et al. Among authors: denhaerynck k. Calcif Tissue Int. 2014 Mar;94(3):311-8. doi: 10.1007/s00223-013-9812-9. Epub 2013 Nov 24. Calcif Tissue Int. 2014. PMID: 24271562 Clinical Trial.

8

Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study).

Gascón P, Aapro M, Ludwig H, Bokemeyer C, Boccadoro M, Turner M, Denhaerynck K, MacDonald K, Abraham I. Gascón P, et al. Among authors: denhaerynck k. Support Care Cancer. 2016 Feb;24(2):911-925. doi: 10.1007/s00520-015-2861-z. Epub 2015 Aug 27. Support Care Cancer. 2016. PMID: 26306517

9

Erratum to: Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study).

Gascón P, Aapro M, Ludwig H, Bokemeyer C, Boccadoro M, Turner M, Denhaerynck K, MacDonald K, Abraham I. Gascón P, et al. Among authors: denhaerynck k. Support Care Cancer. 2016 Feb;24(2):927. doi: 10.1007/s00520-015-2991-3. Support Care Cancer. 2016. PMID: 26482380 No abstract available.

10

Patient engagement impacts glycemic management with vildagliptin and vildagliptin/metformin (single pill) regimens in type 2 diabetes mellitus (the GLORIOUS study).

Hermans M, Van Gaal L, Rézette I, Daci E, MacDonald K, Denhaerynck K, Vancayzeele S, De Meester L, Clemens A, Yee B, Abraham I. Hermans M, et al. Among authors: denhaerynck k. Prim Care Diabetes. 2016 Dec;10(6):425-433. doi: 10.1016/j.pcd.2016.05.008. Epub 2016 Jul 4. Prim Care Diabetes. 2016. PMID: 27388795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page